EA
BSTC

Emerald Acquisition’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Emerald Acquisition’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.58M Sell
56,500
-16,224
-22% -$652K 0.01% 1608
2016
Q2 		$2.9M Buy
+72,724
New +$2.66M 0.01% 1646

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Emerald Acquisition's BSTC Position: Q3 2016 in Review

Emerald Acquisition reduced its BioSpecifics Technologies Corp. (BSTC) stake by 22% in Q3 2016, selling an estimated $652K and leaving 56,500 shares worth $2.58M. The position accounts for 0.01% of the portfolio, ranked #1608.

Emerald Acquisition first reported a position in BSTC in Q2 2016 and has held it in 2 quarters since. The position peaked at $2.9M in Q2 2016. 90 funds tracked by Wall St. Rank hold BSTC as of Q3 2016.

  • Emerald Acquisition held 56,500 shares of BioSpecifics Technologies Corp. worth $2.58M as of Q3 2016.
  • Emerald Acquisition sold 16,224 BioSpecifics Technologies Corp. shares in Q3 2016, an estimated $652K.
  • BioSpecifics Technologies Corp. made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1608 holding.
  • Emerald Acquisition first reported a position in BioSpecifics Technologies Corp. in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's BioSpecifics Technologies Corp. position peaked at $2.9M in Q2 2016.
  • 90 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.